4-n-butylaminobenzoic acid,
para-butylaminobenzoic acid,
4-(Butylamino)benzoic acid,
4740-24-3,
Benzoic acid, 4-(butylamino)-,
4-n-Butylaminobenzoic acid,
4-Butylamino-benzoic acid,
UNII-KGL80FSD2F,
butyl-para-aminobenzoic acid,
4-Butylaminobenzoic acid,
KGL80FSD2F,
p-(butylamino)benzoic acid,
4-(N-butylamino)benzoic acid,
CHEBI:521021,
AK158040,
para-Butylaminobenzoic acid,
NSC 44300,
Tetracaine Impurity B,
4-(butylamino)benzoic,
p-butylaminobenzoic acid,
ACMC-1APGA,
AC1L3VFU,
AC1Q5U0T,
Cambridge id 5117238,
CBDivE_002387,
MLS000776796,
BIDD:GT0564,
SCHEMBL417750,
CHEMBL253121,
CTK1D7781,
KS-00000NSF,
DTXSID60197127,
YCCRFDDXAVMSLM-UHFFFAOYSA-N,
HMS1577I12,
HMS2749N17,
4-(Butylamino)benzoic acid, 97%,
ALBB-026165,
NSC44300,
ZINC1676685,
ZX-AN024677,
5878AF,
BBL023421,
MFCD00002536,
NSC-44300,
SBB056555,
STK736856,
AKOS001705406,
ACM4740243,
BBV-183003,
CS-W008661,
DS-9129,
MCULE-3907451525,
OR19582,
ACM32760160,
NCGC00246412-01,
AJ-29454,
CC-16750,
SMR000413195,
AB0075590,
AX8091115,
ST2405426,
TC-169303,
4CH-018761,
FT-0710002,
R1043,
ST45029473,
AB00653397-06,
C-33499,
SR-01000517796,
SR-01000517796-1,
Tetracaine Related Compound B, United States Pharmacopeia (USP) Reference Standard,
Benzonatate,
4- BENZOICACID,
C11H15NO2,
CID95946,
AR-1F6737,
C11-H15-N-O2,
50390-51-7,